1 2 3
News & Information
Exciting New Treatment Breakthroughs

Prostate cancer clinical trials using Prostate-Specific-Membrane Antigen (PSMA) are ushering in a new generation of treatment therapies and diagnostic tools offering breakthrough benefits for patients.


Barney Morris Survivor Story

PHEN Network member Barney Morris speaks about his prostate cancer journey at the American Society of Radiation Oncology (ASTRO) Annual Meeting.

Webinar: Making Clinical Trials Work For You!

Clinical trials are important treatment options all along your prostate cancer journey.

Dr. Keith Crawford presents clinical trial opportunities that are available and how to make them work for you. 

Understand Your Prostate Cancer Risk Level

Risk levels are determined by PSA Numbers, Biopsy Results, Gleason Scores, Grade Groups and Cancer Stage.

PSMA, What It Is and Why It Matters To Prostate Cancer Patients

Dr. Keith Crawford explains differences between PSA and PSMA, Dr. Michael Morris discusses successful VISION clinical trial and Dr. Michael Groaning discusses Amgen's AMG160 clinical trial.